NEWRONIKA
Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS ... Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
NEWRONIKA
Industry:
Bioinformatics Biotechnology Health Care Hospital Medical Device
Founded:
2008-01-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.newronika.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apache Euro Apache 2.4 Ubuntu
Similar Organizations
Compliant Concept
Compliant Concept is an innovative technologies for care.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Jefferson Health System
Jefferson Health System is a health care company that offers an extended care community for personal health.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innogest Capital
Innogest Capital investment in Series A - Newronika
Indaco Venture Partners
Indaco Venture Partners investment in Series A - Newronika
F3F
F3F investment in Series A - Newronika
Omnes Capital
Omnes Capital investment in Series A - Newronika
Innogest Capital
Innogest Capital investment in Venture Round - Newronika
Laura Iris Ferro
Laura Iris Ferro investment in Venture Round - Newronika
Atlante Ventures
Atlante Ventures investment in Venture Round - Newronika
F3F
F3F investment in Venture Round - Newronika
Atlante Ventures
Atlante Ventures investment in Seed Round - Newronika
Official Site Inspections
http://www.newronika.com Semrush global rank: 5.32 M Semrush visits lastest month: 1.56 K
- Host name: ec2-54-93-67-207.eu-central-1.compute.amazonaws.com
- IP address: 54.93.67.207
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Newronika"
Newronika
Newronika builds innovative neural devices based on its vast knowledge of biosignal decoding About us AlphaDBS. AlphaDBS is a closed-loop brain neuromodulation implant. AlphaDBS …See details»
Newronika / About Us
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. We …See details»
Newronika
LEGAL OFFICE via Dante, 4 20121, Milan (MI) - Italy VAT IT 06399770962 REA MI-1890329 OPERATIVE LABS via Milano, 150 20093, Cologno Monzese (MI) – ItalySee details»
Newronika - Crunchbase Company Profile & Funding
Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, …See details»
Newronika S.p.A. - LinkedIn
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan.See details»
Newronika Company Profile 2024: Valuation, Funding & Investors
Newronika was founded in 2008. Where is Newronika headquartered? Newronika is headquartered in Milan, Italy. What is the size of Newronika? Newronika has 23 total …See details»
Newronika Sercures Initial €2 Million in Blended Finance from EIC ...
Milan, January 22, 2024 – Newronika S.P.A – a pioneering Milan-based leader in adaptive deep brain stimulation and brain device interface technology – has achieved a major milestone in its …See details»
Newronika Company Profile - Office Locations, Competitors, …
See insights on Newronika including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
NEWRONIKA SPA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEWRONIKA SPA of MILANO, MILANO. Get the latest business insights from Dun & Bradstreet.See details»
Newronika Announces First Patient Implanted with AlphaDBSTM …
Feb 4, 2021 · Newronika has initiated a multi-center clinical trial to evaluate the AlphaDBS adaptive closed-loop system in patients with Parkinson's disease. The first implant was …See details»
Newronika Interview - Italy Life Sciences 2021
Newronika is developing the first functionally integrated technology into the brain. Can you explain the functions of the Alfa DBS system and the Web Biobank? DBS was invented about 20 years ago and it was designed to replace a …See details»
Newronika | VentureRadar
Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. …See details»
Newronika - Funding, Financials, Valuation & Investors - Crunchbase
Newronika restores brain and body functions with innovative technologies.See details»
Newronika - Company Profile - Tracxn
Oct 31, 2024 · Newronika - Developer of devices for neurodegenerative diseases. Raised a total funding of $11.1M over 3 rounds from 6 investors. Founded by Alberto Priori in the year 2016. …See details»
Newronika raises an €8.4 m series-A round - Omnes Capital
Newronika, a spin-off of world-class neurological research center Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by …See details»
Newronika Announces CE Mark Approval for AlphaDBS™ System …
Feb 23, 2021 · Newronika (www.newronika.com) is the spin-off company of two of the world-leading research institutions in the field of neurology, the Fondazione IRCCS Ca'Granda …See details»
Newronika - Products, Competitors, Financials, Employees, …
Newronika focuses on developing neural devices within the biomedical engineering and neurotechnology sectors. The company specializes in creating brain neuromodulation implants …See details»
Newronika / Technology
Traditional deep brain stimulation devices deliver stimulation at a constant rate to targeted areas of the brain to help manage symptoms of Parkinson's patients. These symptoms are dynamic …See details»
NEWRONIKA SECURES 2.5 MILLION EUROS GRANT FROM EIC …
Mar 10, 2023 · Milan, March 8, 2023 – Newronika S.P.A, a Milan based leader in adaptive deep brain stimulation and brain device interface technology, has signed a €2.5M grant agreement …See details»
Newronika raises €8m Series A for closed-loop DBS
Sep 27, 2019 · Newronika said yesterday that it raised more than $9 million in Series A funding for its closed-loop deep brain stimulation system. The funding totals nearly $9.2 million (€8.4 …See details»